<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03562442</url>
  </required_header>
  <id_info>
    <org_study_id>SAW Lungenmikrobiom-Studie</org_study_id>
    <nct_id>NCT03562442</nct_id>
  </id_info>
  <brief_title>SAW Lung Microbiome Study in Smokers and Never-smokers</brief_title>
  <official_title>Leibniz Association Senate Board of Competition (SAW) Lung Microbiome Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Research Center Borstel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leibniz Institute of Photonic Technology (IPHT), Jena, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technical University of Munich, Helmholtz Center Munich, Munich Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Research Center Borstel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial aims to analyse changes in the microbiome of the lower airways after smoking&#xD;
      cessation. Microbiome analyses (upper airway swabs, bronchoalveolar lavage, transbronchial&#xD;
      brushing) are conducted in smokers before and 6 weeks after smoking cessation. Never smokers&#xD;
      serve as a control group and undergo the same sampling procedures once.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The trial aims to analyze changes in the microbiome of the lower airways after smoking&#xD;
      cessation. Microbiome analyses (upper airway swabs, bronchoalveolar lavage, transbronchial&#xD;
      brushing) are conducted in healthy (and willing to quit) smokers before and 6 weeks after&#xD;
      smoking cessation. Never smokers serve as a control group and undergo the same sampling&#xD;
      procedures once.&#xD;
&#xD;
      Demographic and clinical data of the study subjects are obtained, aiming for homogeneous&#xD;
      groups. All personal data are encrypted according to the standard operating procedures of the&#xD;
      study site. Pharyngeal and deep nasal swabs are taken.&#xD;
&#xD;
      To avoid contamination of the lower airways from the oropharynx through the bronchoscope,&#xD;
      standardized procedures are established according to the German guidelines for bronchoscopy.&#xD;
      Before bronchoscopy, the endoscope is flushed with sterile saline which is analyzed for 16S&#xD;
      ribosomal RNA (rRNA) to control for residual contaminating bacterial desoxyribonucleic acid&#xD;
      (DNA). A 300ml bronchoalveolar lavage with warm normal saline solution is taken from the&#xD;
      middle lobe. Three covered and &quot;microbiologically protected&quot; bronchial brushings are obtained&#xD;
      from the right upper lobe. This sterile brush is sealed in wax and pushed through the wax&#xD;
      just before taking the brushing. All samples are immediately frozen and stored at -80°C until&#xD;
      further analyses. For cultivations, samples are kept at 4°C and rapidly processed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 29, 2017</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups are recruited in parallel (A) Smokers who quit smoking (Visit 1 before cessation, Visit 2 six weeks after cessation) (B) Never-smokers (Visit 1 only)</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in microbiome pattern in smokers after smoking cessation</measure>
    <time_frame>6 Weeks</time_frame>
    <description>Number of bacteria genera in the lung identified by 16S rRNA and bacterial culture</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation rates</measure>
    <time_frame>6 weeks</time_frame>
    <description>Percentage of sustained smoking cessation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation rates</measure>
    <time_frame>6 months</time_frame>
    <description>Percentage of sustained smoking cessation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung microbiome in never-smokers</measure>
    <time_frame>0 days</time_frame>
    <description>Number of bacteria genera in the lung identified by 16S rRNA and bacterial culture</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <condition>Healthy</condition>
  <condition>Microbial Colonization</condition>
  <arm_group>
    <arm_group_label>Smokers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy caucasian smokers who are willing to quit smoking are investigated before cessation (Visit 1) and 6 weeks after cessation (Visit 2).&#xD;
Intervention: Smoking cessation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Never-Smokers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy caucasian volunteers who never smoked are investigated once only (Visit 1)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Smoking cessation</intervention_name>
    <description>Smoking cessation with or without professional / medical support</description>
    <arm_group_label>Smokers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cigarette consumption of at least five cigarettes per day&#xD;
&#xD;
          -  Caucasian ethnicity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Continous passive smoking exposure&#xD;
&#xD;
          -  Systemic steroid therapy during the previous month&#xD;
&#xD;
          -  Chronic lung disease (exception COPD stage Global Initiative on Lung Disease (GOLD)&#xD;
             0/I/II)&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  active tuberculosis (currently or previously)&#xD;
&#xD;
          -  respiratory infection in the previous month&#xD;
&#xD;
          -  antibiotic therapy in the previous two months&#xD;
&#xD;
          -  immunosuppression&#xD;
&#xD;
          -  malignancy&#xD;
&#xD;
          -  interstitial lung disease&#xD;
&#xD;
          -  rheumatic disease with lung manifestation&#xD;
&#xD;
          -  member of a collaborative group of the project&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Research Center Borstel</name>
      <address>
        <city>Borstel</city>
        <state>Schleswig-Holstein</state>
        <zip>23845</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 26, 2018</study_first_submitted>
  <study_first_submitted_qc>June 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2018</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

